Tycoon Group Holdings Limited (HK:3390)
:3390
Want to see HK:3390 full AI Analyst Report?
3390 Stock Chart & Stats
HK$0.29
HK$0.01(0.29%)
At close: 4:00 PM EST
HK$0.29
HK$0.01(0.29%)
Day’s Range― - ―
52-Week RangeHK$0.22 - HK$0.58
Previous CloseN/A
Volume590.00K
Average Volume (3M)1.30M
Market Cap
HK$236.91M
Enterprise ValueHK$594.63M
Total Cash (Recent Filing)HK$70.34M
Total Debt (Recent Filing)HK$428.05M
Price to Earnings (P/E)15.2
Beta0.05
Next Earnings
Aug 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield28%
Share Statistics
EPS (TTM)0.03
Shares Outstanding894,000,000
10 Day Avg. Volume1,126,200
30 Day Avg. Volume1,299,466
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)0.44
Price to Sales (P/S)0.22
P/FCF Ratio2.47
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue And Cash Flow RecoveryA clear rebound in 2025 revenue and the return to positive operating and free cash flow materially improves the company's ability to self-fund operations, service obligations and invest in distribution or inventory. This restores financial flexibility and reduces near-term reliance on external financing for working capital or growth initiatives.
Distribution-focused Business ModelA distribution-centric model serving pharmacies, retailers and other channel partners provides recurring demand and diversified customer exposure across the healthcare supply chain. Strong supplier and channel relationships can create stable revenue streams, operational scalability and defensive end-market exposure versus cyclical consumer segments.
Capital Base Supported By Equity GrowthGrowing equity alongside moderate leverage strengthens the balance sheet, increasing solvency headroom and the company's capacity to absorb shocks or fund inventory-heavy operations. A healthier capital base enables strategic optionality—such as supplier financing, expansion or working-capital smoothing—without immediately overleveraging the company.
Bears Say
Thin And Eroding MarginsVery thin operating and net margins limit the firm's ability to absorb cost inflation, invest in growth, or withstand price competition. The decline in gross margin points to upstream cost pressure or weaker pricing power; structurally low margins constrain long-term profitability and reduce returns even if revenue recovers.
Volatile Earnings And Cash FlowsLarge year-to-year swings in earnings and cash generation undermine management's ability to plan capex, manage working capital, and justify recurring investments. Volatility raises financing costs, complicates supplier and customer negotiations, and means a single strong year may not signal sustainable improvement without structural margin or revenue mix changes.
Rising Leverage And Low ROEIncreasing indebtedness combined with very low ROE indicates the company is not efficiently converting capital into profits. Higher leverage raises financial risk in downturns and limits capacity for M&A or growth spending. Low capital returns may also constrain investor and lender confidence over the medium term.
Tycoon Group Holdings Limited News
3390 FAQ
What was Tycoon Group Holdings Limited’s price range in the past 12 months?
Tycoon Group Holdings Limited lowest stock price was HK$0.22 and its highest was HK$0.58 in the past 12 months.
What is Tycoon Group Holdings Limited’s market cap?
Tycoon Group Holdings Limited’s market cap is HK$236.91M.
When is Tycoon Group Holdings Limited’s upcoming earnings report date?
Tycoon Group Holdings Limited’s upcoming earnings report date is Aug 28, 2026 which is in 121 days.
How were Tycoon Group Holdings Limited’s earnings last quarter?
Tycoon Group Holdings Limited released its earnings results on Mar 31, 2026. The company reported HK$0.026 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.026.
Is Tycoon Group Holdings Limited overvalued?
According to Wall Street analysts Tycoon Group Holdings Limited’s price is currently Overvalued.
Does Tycoon Group Holdings Limited pay dividends?
Tycoon Group Holdings Limited pays a Notavailable dividend of HK$0.035 which represents an annual dividend yield of 28%. See more information on Tycoon Group Holdings Limited dividends here
What is Tycoon Group Holdings Limited’s EPS estimate?
Tycoon Group Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tycoon Group Holdings Limited have?
Tycoon Group Holdings Limited has 894,000,000 shares outstanding.
What happened to Tycoon Group Holdings Limited’s price movement after its last earnings report?
Tycoon Group Holdings Limited reported an EPS of HK$0.026 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 5.882%.
Which hedge fund is a major shareholder of Tycoon Group Holdings Limited?
Currently, no hedge funds are holding shares in HK:3390
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Tycoon Group Holdings Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-91.87%
12-Months-Change
Fundamentals
Return on Equity
2.98%
Trailing 12-Months
Asset Growth
16.38%
Trailing 12-Months
Company Description
Tycoon Group Holdings Limited
Tycoon Group Holdings Limited, an investment holding company, distributes and retails a suite of health and well-being related products in Hong Kong, Mainland China, Macau, and internationally. It operates through three segments: Distribution, E-Commerce, and Retail Stores. The company offers proprietary Chinese medicine, health supplement, skin care, personal care, and other healthcare products under the third-party and private label brands. It sells its products to chain retailers, non-chain retailers, and traders; and through its brick-and-mortar retail stores as well as online stores. The company was founded in 2015 and is headquartered in Shatin, Hong Kong.
Technical Analysis
Kingworld Medicines Group Ltd.
―
New Century Healthcare Holding Co. Ltd.
―
Vincent Medical Holdings Limited
―
Modern Chinese Medicine Group Co. Ltd.
―
Yestar Healthcare Holdings Co Ltd
―
Options Prices
Currently, No data available
---